{"id":8750,"date":"2026-09-22T22:18:28","date_gmt":"2026-09-23T02:18:28","guid":{"rendered":"https:\/\/www.gensight-biologics.com\/investisseurs\/communiques-de-presse-financiers\/"},"modified":"2026-09-22T22:18:34","modified_gmt":"2026-09-23T02:18:34","slug":"communiques-de-presse-financiers","status":"publish","type":"page","link":"https:\/\/www.gensight-biologics.com\/fr\/investisseurs\/communiques-de-presse-financiers\/","title":{"rendered":"Communiqu\u00e9s de presse financiers"},"content":{"rendered":"\n<style type=\"text\/css\" data-created_by=\"avia_inline_auto\" id=\"style-css-av-mr9tan97-74069aef58cff968700cf4cda735227c\">\n.avia-section.av-mr9tan97-74069aef58cff968700cf4cda735227c{\nbackground-color:#0e1539;\nbackground-image:unset;\n}\n<\/style>\n<div id='av_section_1'  class='avia-section av-mr9tan97-74069aef58cff968700cf4cda735227c main_color avia-section-huge avia-no-border-styling  avia-builder-el-0  el_before_av_section  avia-builder-el-first  invalid-custom-class-found page-banner unset-row huge-padding-bottom avia-bg-style-scroll container_wrap sidebar_right'  ><div class='container av-section-cont-open' ><main  role=\"main\" itemprop=\"mainContentOfPage\"  class='template-page content  av-content-small alpha units'><div class='post-entry post-entry-type-page post-entry-8750'><div class='entry-content-wrapper clearfix'>\n\n<style type=\"text\/css\" data-created_by=\"avia_inline_auto\" id=\"style-css-av-ks357-3d9f39e6e8ff3fd43faf84466bf56bc6\">\n.avia-image-container.av-ks357-3d9f39e6e8ff3fd43faf84466bf56bc6 img.avia_image{\nbox-shadow:none;\n}\n.avia-image-container.av-ks357-3d9f39e6e8ff3fd43faf84466bf56bc6 .av-image-caption-overlay-center{\ncolor:#ffffff;\n}\n<\/style>\n<div  class='avia-image-container av-ks357-3d9f39e6e8ff3fd43faf84466bf56bc6 av-styling- av-hover-fade avia-align-center  avia-builder-el-1  el_before_av_one_full  avia-builder-el-first  center-left-dots-img animated-dots'   itemprop=\"image\" itemscope=\"itemscope\" itemtype=\"https:\/\/schema.org\/ImageObject\" ><div class=\"avia-image-container-inner\"><div class=\"avia-image-overlay-wrap\"><img decoding=\"async\" fetchpriority=\"high\" class='wp-image-8016 avia-img-lazy-loading-not-8016 avia_image fade-basic' src=\"https:\/\/www.gensight-biologics.com\/wp-content\/uploads\/2026\/07\/ani-dots-1.svg\" alt='' title='ani-dots-1'  height=\"500\" width=\"90\"  itemprop=\"thumbnailUrl\"  \/><img decoding=\"async\" class='wp-image-8019 avia-img-lazy-loading-not-8019 avia_image fade-overlay' src=\"https:\/\/www.gensight-biologics.com\/wp-content\/uploads\/2026\/07\/ani-dots-2.svg\" alt='' title='ani-dots-1'  height=\"500\" width=\"90\"  itemprop=\"thumbnailUrl\"  \/><\/div><\/div><\/div>\n<div  class='flex_column av-dsue3-e2b6e9cbfb39814c3caec97f0019bac0 av_one_full  avia-builder-el-2  el_after_av_image  el_before_av_one_full  first flex_column_div av-animated-generic bottom-to-top  '     ><section  class='av_textblock_section av-mr9tcil9-5275af21e20141a221a514141909d329 '   itemscope=\"itemscope\" itemtype=\"https:\/\/schema.org\/CreativeWork\" ><div class='avia_textblock page-banner-content'  itemprop=\"text\" ><h1>Communiqu\u00e9s de presse financiers<\/h1>\n<\/div><\/section><br \/>\n\n<style type=\"text\/css\" data-created_by=\"avia_inline_auto\" id=\"style-css-av-mrati36j-178876a6f71cc466558f5e323577de66\">\n#top .hr.hr-invisible.av-mrati36j-178876a6f71cc466558f5e323577de66{\nheight:30px;\n}\n<\/style>\n<div  class='hr av-mrati36j-178876a6f71cc466558f5e323577de66 hr-invisible  avia-builder-el-4  el_after_av_textblock  el_before_av_textblock '><span class='hr-inner '><span class=\"hr-inner-style\"><\/span><\/span><\/div><br \/>\n<section  class='av_textblock_section av-mrat8be0-e1c8dcfcf47dc79b3e40b067835078a2 '   itemscope=\"itemscope\" itemtype=\"https:\/\/schema.org\/CreativeWork\" ><div class='avia_textblock filter-column-flex'  itemprop=\"text\" ><p>Filtrer par <div class=\"wpgb-facet wpgb-loading wpgb-facet-10\" data-facet=\"10\" data-grid=\"4\">\t<fieldset>\n\t\t<legend class=\"wpgb-facet-title wpgb-sr-only\">Filter By Year (Posts)<\/legend>\n\t\t<div class=\"wpgb-select-facet\"><label><span class=\"wpgb-sr-only\">S\u00e9lectionnez le contenu<\/span><select class=\"wpgb-select\" name=\"category_facet_2_2\"><option value=\"\">Ann\u00e9e<\/option><option value=\"2026\">2026<\/option><\/select><span class=\"wpgb-select-controls\"><span class=\"wpgb-select-separator\"><\/span><svg class=\"wpgb-select-toggle\" viewBox=\"0 0 24 24\" height=\"24\" width=\"24\" aria-hidden=\"true\" focusable=\"false\"><path d=\"m12 14.536-.045.043.045-.043-5.3-5.114 5.3 5.114 5.3-5.114-5.3 5.114.045.043Z\"\/><\/svg><\/span><\/label><\/div>\t<\/fieldset>\n\t<\/div><div class=\"wpgb-facet wpgb-loading wpgb-facet-4\" data-facet=\"4\" data-grid=\"4\">\t<fieldset>\n\t\t<legend class=\"wpgb-facet-title wpgb-sr-only\">News Types<\/legend>\n\t\t<div class=\"wpgb-select-facet\"><label><span class=\"wpgb-sr-only\">S\u00e9lectionnez le contenu<\/span><select class=\"wpgb-select\" name=\"category_facet\"><option value=\"\">Type d&#039;actualit\u00e9<\/option><option value=\"clinical\">Clinical<\/option><option value=\"conferences\">Conferences<\/option><option value=\"corporate\">Corporate<\/option><option value=\"finance\">Finance<\/option><option value=\"general-meeting\">General Meeting<\/option><option value=\"product-candidates\">Product candidates<\/option><option value=\"regulatory\">Regulatory<\/option><\/select><span class=\"wpgb-select-controls\"><span class=\"wpgb-select-separator\"><\/span><svg class=\"wpgb-select-toggle\" viewBox=\"0 0 24 24\" height=\"24\" width=\"24\" aria-hidden=\"true\" focusable=\"false\"><path d=\"m12 14.536-.045.043.045-.043-5.3-5.114 5.3 5.114 5.3-5.114-5.3 5.114.045.043Z\"\/><\/svg><\/span><\/label><\/div>\t<\/fieldset>\n\t<\/div><div class=\"wpgb-facet wpgb-loading wpgb-facet-5\" data-facet=\"5\" data-grid=\"4\">\t<fieldset>\n\t\t<legend class=\"wpgb-facet-title wpgb-sr-only\">Keyword<\/legend>\n\t\t<div class=\"wpgb-search-facet\"><label>\n\t\t\t\t<span class=\"wpgb-sr-only\">Rechercher<\/span>\n\t\t\t\t<input class=\"wpgb-input\" type=\"search\" name=\"keyword\" placeholder=\"Rechercher par mot-cl\u00e9\" value=\"\" autocomplete=\"off\">\n\t\t\t\t<svg class=\"wpgb-input-icon\" viewBox=\"0 0 24 24\" height=\"16\" width=\"16\" aria-hidden=\"true\" focusable=\"false\"><path d=\"M17.5 17.5 23 23Zm-16-7a9 9 0 1 1 9 9 9 9 0 0 1-9-9Z\"\/><\/svg>\n\t\t\t<\/label><button type=\"button\" class=\"wpgb-clear-button\" hidden><span class=\"wpgb-sr-only\">Effacer<\/span><svg viewBox=\"0 0 24 24\" height=\"24\" width=\"24\" aria-hidden=\"true\" focusable=\"false\"><path d=\"m12 12-4.25 4.75L12.001 12 7.75 7.25 12.001 12l4.249-4.75L12 12l4.25 4.75Z\"\/><\/svg><\/button><\/div>\t<\/fieldset>\n\t<\/div><div class=\"wpgb-facet wpgb-loading wpgb-facet-6\" data-facet=\"6\" data-grid=\"4\"><button type=\"button\" class=\"wpgb-button wpgb-apply\" name=\"submit\">Valider<\/button><\/div><\/p>\n<\/div><\/section><\/p><\/div><div class='flex_column_table av-mravn0ao-3da921c760fa79d658f7680f45a90cfb sc-av_one_full av-equal-height-column-flextable'>\n<style type=\"text\/css\" data-created_by=\"avia_inline_auto\" id=\"style-css-av-mravn0ao-3da921c760fa79d658f7680f45a90cfb\">\n.flex_column.av-mravn0ao-3da921c760fa79d658f7680f45a90cfb{\nwidth:100%;\nmargin-left:0;\n}\n#top .flex_column_table.av-equal-height-column-flextable.av-mravn0ao-3da921c760fa79d658f7680f45a90cfb .av-flex-placeholder{\nwidth:0%;\n}\n<\/style>\n<div  class='flex_column av-mravn0ao-3da921c760fa79d658f7680f45a90cfb av_one_full  avia-builder-el-6  el_after_av_one_full  avia-builder-el-last  first flex_column_table_cell av-equal-height-column av-align-top av-animated-generic bottom-to-top  column-top-margin'     ><section  class='av_textblock_section av-mravmvfj-5d78affce8b49a660746dd6f85b7bae7 '   itemscope=\"itemscope\" itemtype=\"https:\/\/schema.org\/CreativeWork\" ><div class='avia_textblock'  itemprop=\"text\" ><!-- Gridbuilder \u1d42\u1d3e Plugin (https:\/\/wpgridbuilder.com) -->\n<div class=\"wp-grid-builder wpgb-grid-4\" data-options=\"{&quot;id&quot;:4,&quot;type&quot;:&quot;masonry&quot;,&quot;source&quot;:&quot;post_type&quot;,&quot;loader&quot;:false,&quot;layout&quot;:&quot;vertical&quot;,&quot;reveal&quot;:0,&quot;isMainQuery&quot;:0,&quot;lazyLoad&quot;:false,&quot;cardSizes&quot;:{&quot;9999&quot;:{&quot;columns&quot;:3,&quot;height&quot;:240,&quot;gutter&quot;:30,&quot;ratio&quot;:&quot;1.33333&quot;},&quot;1280&quot;:{&quot;columns&quot;:3,&quot;height&quot;:220,&quot;gutter&quot;:16,&quot;ratio&quot;:&quot;1.33333&quot;},&quot;1024&quot;:{&quot;columns&quot;:2,&quot;height&quot;:200,&quot;gutter&quot;:16,&quot;ratio&quot;:&quot;1.33333&quot;},&quot;640&quot;:{&quot;columns&quot;:1,&quot;height&quot;:200,&quot;gutter&quot;:16,&quot;ratio&quot;:&quot;1.33333&quot;}},&quot;fitRows&quot;:false,&quot;equalRows&quot;:0,&quot;equalColumns&quot;:true,&quot;fillLastRow&quot;:0,&quot;centerLastRow&quot;:0,&quot;horizontalOrder&quot;:false,&quot;fullWidth&quot;:false,&quot;transitionDelay&quot;:100,&quot;gallerySlideshow&quot;:false,&quot;rowsNumber&quot;:1,&quot;slideAlign&quot;:&quot;left&quot;,&quot;groupCells&quot;:1,&quot;draggable&quot;:true,&quot;initialIndex&quot;:0,&quot;contain&quot;:false,&quot;freeScroll&quot;:false,&quot;freeFriction&quot;:&quot;0.075&quot;,&quot;friction&quot;:&quot;0.285&quot;,&quot;attraction&quot;:&quot;0.025&quot;,&quot;autoPlay&quot;:0,&quot;pageDotAriaLabel&quot;:&quot;Point de page %d&quot;,&quot;isPreview&quot;:false,&quot;isGutenberg&quot;:false,&quot;rightToLeft&quot;:false}\"><div class=\"wpgb-svg-icons\" hidden>\n\t<svg viewBox=\"0 0 120 24\" width=\"0\" height=\"0\">\n\t<defs>\n        <polygon id=\"wpgb-star-svg\" points=\"12 2.5 15.1 8.8 22 9.8 17 14.6 18.2 21.5 12 18.3 5.8 21.5 7 14.6 2 9.8 8.9 8.8\"><\/polygon>\n    <\/defs>\n    <symbol id=\"wpgb-rating-stars-svg\">\n        <use xlink:href=\"#wpgb-star-svg\"><\/use>\n        <use xlink:href=\"#wpgb-star-svg\" x=\"24\"><\/use>\n        <use xlink:href=\"#wpgb-star-svg\" x=\"48\"><\/use>\n        <use xlink:href=\"#wpgb-star-svg\" x=\"72\"><\/use>\n        <use xlink:href=\"#wpgb-star-svg\" x=\"96\"><\/use>\n    <\/symbol>\n<\/svg>\n<\/div>\n<div class=\"wpgb-wrapper\">\n\t<div class=\"wpgb-main\">\n\t<div class=\"wpgb-layout\">\n\t<div class=\"wpgb-viewport\">\n\t\t<div class=\"wpgb-masonry\">\n\t\t\t<article class=\"wpgb-card wpgb-card-9 wpgb-post-9740\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1\"><time class=\"wpgb-block-3\" datetime=\"2026-10-16T10:49:12+02:00\">16 octobre 2026<\/time><\/div><h3 class=\"wpgb-block-2\"><a href=\"https:\/\/www.gensight-biologics.com\/fr\/2026\/10\/16\/gensight-biologics-annonce-le-reglement-livraison-de-sa-levee-de-fonds-de-10-million-deuros-soutenue-par-ses-actionnaires-existants\/\">GenSight Biologics annonce le r\u00e8glement-livraison de sa lev\u00e9e de fonds de 1,0 million d\u2019euros soutenue par ses actionnaires existants<\/a><\/h3><a class=\"wpgb-block-5 link-with-arrow\" target=\"_self\" href=\"https:\/\/www.gensight-biologics.com\/fr\/2026\/10\/16\/gensight-biologics-annonce-le-reglement-livraison-de-sa-levee-de-fonds-de-10-million-deuros-soutenue-par-ses-actionnaires-existants\/\">Lire la suite<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-9 wpgb-post-9736\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1\"><time class=\"wpgb-block-3\" datetime=\"2026-10-08T10:48:32+02:00\">8 octobre 2026<\/time><\/div><h3 class=\"wpgb-block-2\"><a href=\"https:\/\/www.gensight-biologics.com\/fr\/2026\/10\/08\/gensight-biologics-et-lhopital-national-des-15-20-annoncent-la-publication-dans-le-nejm-des-resultats-de-lessai-de-phase-1-2-evaluant-gs030-dans-la-retinopathie-pigmentaire-au-stade\/\">GenSight Biologics et l\u2019H\u00f4pital National des 15-20 annoncent la publication dans le NEJM des r\u00e9sultats de l\u2019essai de Phase 1\/2 \u00e9valuant GS030 dans la r\u00e9tinopathie pigmentaire au stade avanc\u00e9<\/a><\/h3><a class=\"wpgb-block-5 link-with-arrow\" target=\"_self\" href=\"https:\/\/www.gensight-biologics.com\/fr\/2026\/10\/08\/gensight-biologics-et-lhopital-national-des-15-20-annoncent-la-publication-dans-le-nejm-des-resultats-de-lessai-de-phase-1-2-evaluant-gs030-dans-la-retinopathie-pigmentaire-au-stade\/\">Lire la suite<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-9 wpgb-post-9732\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1\"><time class=\"wpgb-block-3\" datetime=\"2026-10-08T10:48:21+02:00\">8 octobre 2026<\/time><\/div><h3 class=\"wpgb-block-2\"><a href=\"https:\/\/www.gensight-biologics.com\/fr\/2026\/10\/08\/gensight-biologics-realise-avec-succes-une-levee-de-fonds-de-10-million-deuros-soutenue-par-ses-actionnaires-existants\/\">GenSight Biologics r\u00e9alise avec succ\u00e8s une lev\u00e9e de fonds de 1,0 million d\u2019euros soutenue par ses actionnaires existants<\/a><\/h3><a class=\"wpgb-block-5 link-with-arrow\" target=\"_self\" href=\"https:\/\/www.gensight-biologics.com\/fr\/2026\/10\/08\/gensight-biologics-realise-avec-succes-une-levee-de-fonds-de-10-million-deuros-soutenue-par-ses-actionnaires-existants\/\">Lire la suite<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-9 wpgb-post-9728\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1\"><time class=\"wpgb-block-3\" datetime=\"2026-10-07T10:46:57+02:00\">7 octobre 2026<\/time><\/div><h3 class=\"wpgb-block-2\"><a href=\"https:\/\/www.gensight-biologics.com\/fr\/2026\/10\/07\/gensight-biologics-publie-sa-situation-de-tresorerie-au-30-septembre-2026\/\">GenSight Biologics publie sa situation de tr\u00e9sorerie au 30 septembre 2026<\/a><\/h3><a class=\"wpgb-block-5 link-with-arrow\" target=\"_self\" href=\"https:\/\/www.gensight-biologics.com\/fr\/2026\/10\/07\/gensight-biologics-publie-sa-situation-de-tresorerie-au-30-septembre-2026\/\">Lire la suite<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-9 wpgb-post-9724\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1\"><time class=\"wpgb-block-3\" datetime=\"2026-09-29T10:41:04+02:00\">29 septembre 2026<\/time><\/div><h3 class=\"wpgb-block-2\"><a href=\"https:\/\/www.gensight-biologics.com\/fr\/2026\/09\/29\/gensight-biologics-publie-ses-resultats-financiers-du-premier-semestre-2026-et-fait-un-point-sur-son-activite\/\">GenSight Biologics publie ses r\u00e9sultats financiers du premier semestre 2026 et fait un point sur son activit\u00e9<\/a><\/h3><a class=\"wpgb-block-5 link-with-arrow\" target=\"_self\" href=\"https:\/\/www.gensight-biologics.com\/fr\/2026\/09\/29\/gensight-biologics-publie-ses-resultats-financiers-du-premier-semestre-2026-et-fait-un-point-sur-son-activite\/\">Lire la suite<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-9 wpgb-post-9718\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1\"><time class=\"wpgb-block-3\" datetime=\"2026-09-08T10:16:56+02:00\">8 septembre 2026<\/time><\/div><h3 class=\"wpgb-block-2\"><a href=\"https:\/\/www.gensight-biologics.com\/fr\/2026\/09\/08\/gensight-biologics-provides-september-2026-business-updates\/\">GenSight Biologics fait un point sur son activit\u00e9 en septembre 2026<\/a><\/h3><a class=\"wpgb-block-5 link-with-arrow\" target=\"_self\" href=\"https:\/\/www.gensight-biologics.com\/fr\/2026\/09\/08\/gensight-biologics-provides-september-2026-business-updates\/\">Lire la suite<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-9 wpgb-post-9714\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1\"><time class=\"wpgb-block-3\" datetime=\"2026-07-08T10:28:17+02:00\">8 juillet 2026<\/time><\/div><h3 class=\"wpgb-block-2\"><a href=\"https:\/\/www.gensight-biologics.com\/fr\/2026\/07\/08\/gensight-biologics-publie-sa-situation-de-tresorerie-au-30-juin-2026-et-fait-un-point-sur-son-activite\/\">GenSight Biologics publie sa situation de tr\u00e9sorerie au 30 juin 2026 et fait un point sur son activit\u00e9<\/a><\/h3><a class=\"wpgb-block-5 link-with-arrow\" target=\"_self\" href=\"https:\/\/www.gensight-biologics.com\/fr\/2026\/07\/08\/gensight-biologics-publie-sa-situation-de-tresorerie-au-30-juin-2026-et-fait-un-point-sur-son-activite\/\">Lire la suite<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-9 wpgb-post-4513\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1\"><time class=\"wpgb-block-3\" datetime=\"2026-05-20T16:00:07+02:00\">20 mai 2026<\/time><\/div><h3 class=\"wpgb-block-2\"><a href=\"https:\/\/www.gensight-biologics.com\/fr\/2026\/05\/20\/gensight-biologics-annonce-les-resultats-de-son-assemblee-generale-du-19-mai-2026\/\">GenSight Biologics annonce les r\u00e9sultats de son Assembl\u00e9e G\u00e9n\u00e9rale du 19 mai 2026<\/a><\/h3><a class=\"wpgb-block-5 link-with-arrow\" target=\"_self\" href=\"https:\/\/www.gensight-biologics.com\/fr\/2026\/05\/20\/gensight-biologics-annonce-les-resultats-de-son-assemblee-generale-du-19-mai-2026\/\">Lire la suite<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-9 wpgb-post-4509\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1\"><time class=\"wpgb-block-3\" datetime=\"2026-05-18T16:30:56+02:00\">18 mai 2026<\/time><\/div><h3 class=\"wpgb-block-2\"><a href=\"https:\/\/www.gensight-biologics.com\/fr\/2026\/05\/18\/gensight-biologics-tiendra-son-assemblee-generale-mixte-le-19-mai-2026\/\">GenSight Biologics tiendra son Assembl\u00e9e G\u00e9n\u00e9rale Mixte le 19 mai 2026<\/a><\/h3><a class=\"wpgb-block-5 link-with-arrow\" target=\"_self\" href=\"https:\/\/www.gensight-biologics.com\/fr\/2026\/05\/18\/gensight-biologics-tiendra-son-assemblee-generale-mixte-le-19-mai-2026\/\">Lire la suite<\/a><\/div><\/div><\/div><\/div><\/article>\t\t<\/div>\n\t<\/div>\n\t<\/div>\n<div class=\"wpgb-area wpgb-area-bottom-1\">\n\t<div class=\"wpgb-facet wpgb-loading wpgb-facet-8\" data-facet=\"8\" data-grid=\"4\"><nav class=\"wpgb-pagination-facet\" aria-label=\"Navigation\"><ul class=\"wpgb-pagination\"><li class=\"wpgb-page\"><a href=\"https:\/\/www.gensight-biologics.com\/fr\/investisseurs\/communiques-de-presse-financiers\/?_pagination=1\" aria-current=\"true\" aria-label=\"Page courante, Page 1\" data-page=\"1\">1<\/a><\/li><li class=\"wpgb-page\"><a href=\"https:\/\/www.gensight-biologics.com\/fr\/investisseurs\/communiques-de-presse-financiers\/?_pagination=2\" aria-label=\"Aller \u00e0 la page 2\" data-page=\"2\">2<\/a><\/li><li class=\"wpgb-page\"><a href=\"https:\/\/www.gensight-biologics.com\/fr\/investisseurs\/communiques-de-presse-financiers\/?_pagination=3\" aria-label=\"Aller \u00e0 la page 3\" data-page=\"3\">3<\/a><\/li><li class=\"wpgb-page\"><span class=\"wpgb-dots-page\">\u2026<\/span><\/li><li class=\"wpgb-page\"><a href=\"https:\/\/www.gensight-biologics.com\/fr\/investisseurs\/communiques-de-presse-financiers\/?_pagination=32\" aria-label=\"Aller \u00e0 la page 32\" data-page=\"32\">32<\/a><\/li><li class=\"wpgb-page\"><a href=\"https:\/\/www.gensight-biologics.com\/fr\/investisseurs\/communiques-de-presse-financiers\/?_pagination=33\" aria-label=\"Aller \u00e0 la page 33\" data-page=\"33\">33<\/a><\/li><li class=\"wpgb-page wpgb-page-next\"><a href=\"https:\/\/www.gensight-biologics.com\/fr\/investisseurs\/communiques-de-presse-financiers\/?_pagination=2\" aria-label=\"Aller \u00e0 la page 2\" data-page=\"2\">&gt;<\/a><\/li><\/ul><\/nav><\/div><\/div>\n\t<\/div>\n\t\t<\/div>\n<\/div>\n\n<\/div><\/section><\/div><\/div><!--close column table wrapper. Autoclose: 1 --><\/div><\/div><\/main><!-- close content main element --><\/div><\/div>\n<style type=\"text\/css\" data-created_by=\"avia_inline_auto\" id=\"style-css-av-jtu4q-e04ecc60c67e01d6808b411610be9fc0\">\n.avia-section.av-jtu4q-e04ecc60c67e01d6808b411610be9fc0{\nbackground-color:#0d304e;\nbackground-image:unset;\n}\n<\/style>\n<div id='av_section_2'  class='avia-section av-jtu4q-e04ecc60c67e01d6808b411610be9fc0 main_color avia-section-default avia-no-border-styling avia-bg-style-scroll container_wrap sidebar_right'  ><div class='container av-section-cont-open' ><div class='template-page content  av-content-small alpha units'><div class='post-entry post-entry-type-page post-entry-8750'><div class='entry-content-wrapper clearfix'>\n<div  class='flex_column av-ex5si-332116ff7361771c703ed251d2a7397d av_one_full first flex_column_div av-animated-generic fade-in  '     ><section  class='av_textblock_section av-mrataq1i-bd6fa670f9f7040a3c3414fb15d9ff1c '   itemscope=\"itemscope\" itemtype=\"https:\/\/schema.org\/BlogPosting\" itemprop=\"blogPost\" ><div class='avia_textblock link-with-arrow'  itemprop=\"text\" ><h3 style=\"text-align: center\">Voir plus<\/h3>\n<\/div><\/section><br \/>\n\n<style type=\"text\/css\" data-created_by=\"avia_inline_auto\" id=\"style-css-av-adloa-656353ce8558d8f2ba1e4c09c4bccede\">\n#top .hr.hr-invisible.av-adloa-656353ce8558d8f2ba1e4c09c4bccede{\nheight:30px;\n}\n<\/style>\n<div  class='hr av-adloa-656353ce8558d8f2ba1e4c09c4bccede hr-invisible'><span class='hr-inner '><span class=\"hr-inner-style\"><\/span><\/span><\/div><br \/>\n<div  class='avia-buttonrow-wrap av-mratbw37-7e461c114f627a124dd8d31c3b6b2b8e avia-buttonrow-center'>\n\n<style type=\"text\/css\" data-created_by=\"avia_inline_auto\" id=\"style-css-av-mratbb6u-4b1f51978506601e2a1d837c21e992ff\">\n#top #wrap_all .avia-button.av-mratbb6u-4b1f51978506601e2a1d837c21e992ff{\nmargin-bottom:5px;\nmargin-right:3px;\nmargin-left:3px;\n}\n<\/style>\n<a href='https:\/\/www.gensight-biologics.com\/fr\/investisseurs\/lettres-aux-actionnaires\/'  class='avia-button av-mratbb6u-4b1f51978506601e2a1d837c21e992ff avia-icon_select-yes-right-icon avia-size-small avia-color-light'   aria-label=\"Lettres aux actionnaires\"><span class='avia_iconbox_title' >Lettres aux actionnaires<\/span><span class='avia_button_icon avia_button_icon_right avia-svg-icon avia-font-svg_entypo-fontello' data-av_svg_icon='right-open-mini' data-av_iconset='svg_entypo-fontello'><svg version=\"1.1\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"8\" height=\"32\" viewBox=\"0 0 8 32\" preserveAspectRatio=\"xMidYMid meet\" aria-labelledby='av-svg-title-1' aria-describedby='av-svg-desc-1' role=\"graphics-symbol\">\n<title id='av-svg-title-1'>Right-open-mini<\/title>\n<desc id='av-svg-desc-1'>Right-open-mini<\/desc>\n<path d=\"M0.416 21.44l5.056-5.44-5.056-5.504q-0.832-0.832 0-1.536 0.832-0.832 1.536 0l6.144 6.208q0.768 0.832 0 1.6l-6.144 6.208q-0.704 0.832-1.536 0-0.832-0.704 0-1.536z\"><\/path>\n<\/svg><\/span><\/a>\n\n<style type=\"text\/css\" data-created_by=\"avia_inline_auto\" id=\"style-css-av-mratb3i7-15aa4c30e366bce5b0bf872b3a615303\">\n#top #wrap_all .avia-button.av-mratb3i7-15aa4c30e366bce5b0bf872b3a615303{\nmargin-bottom:5px;\nmargin-right:3px;\nmargin-left:3px;\n}\n<\/style>\n<a href='https:\/\/www.gensight-biologics.com\/investors\/financial-information\/'  class='avia-button av-mratb3i7-15aa4c30e366bce5b0bf872b3a615303 avia-icon_select-yes-right-icon avia-size-small avia-color-light'   aria-label=\"Informations financi\u00e8res\"><span class='avia_iconbox_title' >Informations financi\u00e8res<\/span><span class='avia_button_icon avia_button_icon_right avia-svg-icon avia-font-svg_entypo-fontello' data-av_svg_icon='right-open-mini' data-av_iconset='svg_entypo-fontello'><svg version=\"1.1\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"8\" height=\"32\" viewBox=\"0 0 8 32\" preserveAspectRatio=\"xMidYMid meet\" aria-labelledby='av-svg-title-2' aria-describedby='av-svg-desc-2' role=\"graphics-symbol\">\n<title id='av-svg-title-2'>Right-open-mini<\/title>\n<desc id='av-svg-desc-2'>Right-open-mini<\/desc>\n<path d=\"M0.416 21.44l5.056-5.44-5.056-5.504q-0.832-0.832 0-1.536 0.832-0.832 1.536 0l6.144 6.208q0.768 0.832 0 1.6l-6.144 6.208q-0.704 0.832-1.536 0-0.832-0.704 0-1.536z\"><\/path>\n<\/svg><\/span><\/a>\n\n<style type=\"text\/css\" data-created_by=\"avia_inline_auto\" id=\"style-css-av-mratbb6u-7-2ef580bd05d6daf1d4ac05209c94ed37\">\n#top #wrap_all .avia-button.av-mratbb6u-7-2ef580bd05d6daf1d4ac05209c94ed37{\nmargin-bottom:5px;\nmargin-right:3px;\nmargin-left:3px;\n}\n<\/style>\n<a href='https:\/\/www.gensight-biologics.com\/fr\/investisseurs\/gouvernance\/'  class='avia-button av-mratbb6u-7-2ef580bd05d6daf1d4ac05209c94ed37 avia-icon_select-yes-right-icon avia-size-small avia-color-light'   aria-label=\"Gouvernance\"><span class='avia_iconbox_title' >Gouvernance<\/span><span class='avia_button_icon avia_button_icon_right avia-svg-icon avia-font-svg_entypo-fontello' data-av_svg_icon='right-open-mini' data-av_iconset='svg_entypo-fontello'><svg version=\"1.1\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"8\" height=\"32\" viewBox=\"0 0 8 32\" preserveAspectRatio=\"xMidYMid meet\" aria-labelledby='av-svg-title-3' aria-describedby='av-svg-desc-3' role=\"graphics-symbol\">\n<title id='av-svg-title-3'>Right-open-mini<\/title>\n<desc id='av-svg-desc-3'>Right-open-mini<\/desc>\n<path d=\"M0.416 21.44l5.056-5.44-5.056-5.504q-0.832-0.832 0-1.536 0.832-0.832 1.536 0l6.144 6.208q0.768 0.832 0 1.6l-6.144 6.208q-0.704 0.832-1.536 0-0.832-0.704 0-1.536z\"><\/path>\n<\/svg><\/span><\/a>\n\n<style type=\"text\/css\" data-created_by=\"avia_inline_auto\" id=\"style-css-av-mratbb6u-6-64e60704bad1385182a981415efc593f\">\n#top #wrap_all .avia-button.av-mratbb6u-6-64e60704bad1385182a981415efc593f{\nmargin-bottom:5px;\nmargin-right:3px;\nmargin-left:3px;\n}\n<\/style>\n<a href='https:\/\/www.gensight-biologics.com\/fr\/investisseurs\/information-reglementee\/'  class='avia-button av-mratbb6u-6-64e60704bad1385182a981415efc593f avia-icon_select-yes-right-icon avia-size-small avia-color-light'   aria-label=\"Information r\u00e9glement\u00e9e\"><span class='avia_iconbox_title' >Information r\u00e9glement\u00e9e<\/span><span class='avia_button_icon avia_button_icon_right avia-svg-icon avia-font-svg_entypo-fontello' data-av_svg_icon='right-open-mini' data-av_iconset='svg_entypo-fontello'><svg version=\"1.1\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"8\" height=\"32\" viewBox=\"0 0 8 32\" preserveAspectRatio=\"xMidYMid meet\" aria-labelledby='av-svg-title-4' aria-describedby='av-svg-desc-4' role=\"graphics-symbol\">\n<title id='av-svg-title-4'>Right-open-mini<\/title>\n<desc id='av-svg-desc-4'>Right-open-mini<\/desc>\n<path d=\"M0.416 21.44l5.056-5.44-5.056-5.504q-0.832-0.832 0-1.536 0.832-0.832 1.536 0l6.144 6.208q0.768 0.832 0 1.6l-6.144 6.208q-0.704 0.832-1.536 0-0.832-0.704 0-1.536z\"><\/path>\n<\/svg><\/span><\/a>\n<\/div><\/p><\/div>\n<\/div><\/div><\/div><!-- close content main div --><\/div><\/div><div id='after_section_2'  class='main_color av_default_container_wrap container_wrap sidebar_right'  ><div class='container av-section-cont-open' ><div class='template-page content  av-content-small alpha units'><div class='post-entry post-entry-type-page post-entry-8750'><div class='entry-content-wrapper clearfix'><\/p>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"featured_media":0,"parent":8705,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":"","_links_to":"","_links_to_target":""},"class_list":["post-8750","page","type-page","status-publish","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Communiqu\u00e9s de presse financiers | GenSight Biologics<\/title>\n<meta name=\"description\" content=\"Consultez les communiqu\u00e9s de presse financiers de GenSight Biologics : actualit\u00e9s de la soci\u00e9t\u00e9, programmes cliniques et \u00e9v\u00e9nements investisseurs.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.gensight-biologics.com\/fr\/investisseurs\/communiques-de-presse-financiers\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Communiqu\u00e9s de presse financiers | GenSight Biologics\" \/>\n<meta property=\"og:description\" content=\"Consultez les communiqu\u00e9s de presse financiers de GenSight Biologics : actualit\u00e9s de la soci\u00e9t\u00e9, programmes cliniques et \u00e9v\u00e9nements investisseurs.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.gensight-biologics.com\/fr\/investisseurs\/communiques-de-presse-financiers\/\" \/>\n<meta property=\"og:site_name\" content=\"GenSight Biologics\" \/>\n<meta property=\"article:modified_time\" content=\"2026-09-23T02:18:34+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data1\" content=\"20 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/investisseurs\\\/communiques-de-presse-financiers\\\/\",\"url\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/investisseurs\\\/communiques-de-presse-financiers\\\/\",\"name\":\"Communiqu\u00e9s de presse financiers | GenSight Biologics\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/#website\"},\"datePublished\":\"2026-09-23T02:18:28+00:00\",\"dateModified\":\"2026-09-23T02:18:34+00:00\",\"description\":\"Consultez les communiqu\u00e9s de presse financiers de GenSight Biologics : actualit\u00e9s de la soci\u00e9t\u00e9, programmes cliniques et \u00e9v\u00e9nements investisseurs.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/investisseurs\\\/communiques-de-presse-financiers\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/investisseurs\\\/communiques-de-presse-financiers\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/investisseurs\\\/communiques-de-presse-financiers\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/home\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Investisseurs\",\"item\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/investisseurs\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Communiqu\u00e9s de presse financiers\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/\",\"name\":\"GenSight Biologics\",\"description\":\"Restoring vision while advancing gene therapy\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Communiqu\u00e9s de presse financiers | GenSight Biologics","description":"Consultez les communiqu\u00e9s de presse financiers de GenSight Biologics : actualit\u00e9s de la soci\u00e9t\u00e9, programmes cliniques et \u00e9v\u00e9nements investisseurs.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.gensight-biologics.com\/fr\/investisseurs\/communiques-de-presse-financiers\/","og_locale":"fr_FR","og_type":"article","og_title":"Communiqu\u00e9s de presse financiers | GenSight Biologics","og_description":"Consultez les communiqu\u00e9s de presse financiers de GenSight Biologics : actualit\u00e9s de la soci\u00e9t\u00e9, programmes cliniques et \u00e9v\u00e9nements investisseurs.","og_url":"https:\/\/www.gensight-biologics.com\/fr\/investisseurs\/communiques-de-presse-financiers\/","og_site_name":"GenSight Biologics","article_modified_time":"2026-09-23T02:18:34+00:00","twitter_card":"summary_large_image","twitter_misc":{"Dur\u00e9e de lecture estim\u00e9e":"20 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.gensight-biologics.com\/fr\/investisseurs\/communiques-de-presse-financiers\/","url":"https:\/\/www.gensight-biologics.com\/fr\/investisseurs\/communiques-de-presse-financiers\/","name":"Communiqu\u00e9s de presse financiers | GenSight Biologics","isPartOf":{"@id":"https:\/\/www.gensight-biologics.com\/fr\/#website"},"datePublished":"2026-09-23T02:18:28+00:00","dateModified":"2026-09-23T02:18:34+00:00","description":"Consultez les communiqu\u00e9s de presse financiers de GenSight Biologics : actualit\u00e9s de la soci\u00e9t\u00e9, programmes cliniques et \u00e9v\u00e9nements investisseurs.","breadcrumb":{"@id":"https:\/\/www.gensight-biologics.com\/fr\/investisseurs\/communiques-de-presse-financiers\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.gensight-biologics.com\/fr\/investisseurs\/communiques-de-presse-financiers\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.gensight-biologics.com\/fr\/investisseurs\/communiques-de-presse-financiers\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.gensight-biologics.com\/fr\/home\/"},{"@type":"ListItem","position":2,"name":"Investisseurs","item":"https:\/\/www.gensight-biologics.com\/fr\/investisseurs\/"},{"@type":"ListItem","position":3,"name":"Communiqu\u00e9s de presse financiers"}]},{"@type":"WebSite","@id":"https:\/\/www.gensight-biologics.com\/fr\/#website","url":"https:\/\/www.gensight-biologics.com\/fr\/","name":"GenSight Biologics","description":"Restoring vision while advancing gene therapy","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.gensight-biologics.com\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"}]}},"_links":{"self":[{"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/pages\/8750","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/comments?post=8750"}],"version-history":[{"count":5,"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/pages\/8750\/revisions"}],"predecessor-version":[{"id":8756,"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/pages\/8750\/revisions\/8756"}],"up":[{"embeddable":true,"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/pages\/8705"}],"wp:attachment":[{"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/media?parent=8750"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}